Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis.
The inhibitory effect of oral administration of betel-leaf extract (BLE) and 2 of its constituents, beta-carotene and alpha-tocopherol, as single agents or in combination with dietary turmeric on methyl(acetoxymethyl)nitrosamine (DMN-OAC)-induced oral carcinogenesis in Syrian hamsters was studied. DMN-OAC was administered twice monthly for 6 months. The chemopreventive effect of BLE or its constituents with turmeric was determined by comparing tumor incidence observed in treated groups with that seen in control animals. The apparent site-specific chemopreventive effect of BLE or its constituents was demonstrated by inhibition of tumor incidence, reduction of tumor burden, extension of the tumor latency period and regression of established, frank tumors. The inhibitory effect of BLE or its constituents combined with turmeric was higher than that of the individual constituents. The study suggests that BLE could be developed as a potential chemopreventive agent for human oral cancer.
Azuine
M A
MA
Carcinogenesis Division, Tata Memorial Centre, Parel, Bombay, India.
Bhide
S V
SV
D000818:Animals; D001114:Areca; D002273:Carcinogens; D002338:Carotenoids / Q000627:therapeutic use; D006224:Cricetinae; D030024:Curcuma; D004128:Dimethylnitrosamine / Q000031:analogs & derivatives; D004354:Drug Screening Assays, Antitumor; D004359:Drug Therapy, Combination; D005260:Female; D008647:Mesocricetus; D009062:Mouth Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D010936:Plant Extracts / Q000627:therapeutic use*; D010946:Plants, Medicinal; D014810:Vitamin E / Q000627:therapeutic use; D019207:beta Carotene
D002273:Carcinogens; D010936:Plant Extracts; D019207:beta Carotene; D014810:Vitamin E; D002338:Carotenoids; C014659:methyl(acetoxymethyl)nitrosamine; C012596:turmeric extract; D004128:Dimethylnitrosamine